Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
CEO: Jason Hollar. Company website
Cardinal Health, Inc. (CAH) trades at $225.38, down 0.42% on the day, as of Sep 20, 2026 12:33 UTC.
Cardinal Health, Inc. has a market capitalisation of $52.79B, calculated from the live CAH share price and shares outstanding.
CAH trades at a trailing P/E of 31.17, from earnings per share of $7.23 over the last twelve months.
Cardinal Health, Inc. generated revenue of $254.25B over the trailing twelve months, which puts the stock at 0.21 times sales.
Yes. Cardinal Health, Inc. pays a dividend yielding 0.96% on the current share price.
CAH has traded between $145.87 and $258.30 over the past 52 weeks, and the last price is 12.7% below that high.
Yes. Cardinal Health, Inc. keeps 0.67% of revenue as net income over the trailing twelve months.
Wall Street analysts rate CAH Buy, with an average price target of $273.22, 21.2% above the current price.
Cardinal Health, Inc. is classified under the Healthcare sector and the Medical - Distribution industry, and is domiciled in US.
Jason Hollar is the chief executive of Cardinal Health, Inc., which employs 61,344 people.
QFI Terminal shows CAH with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open CAH in Terminal See plans